Utah Medical Products (UTMD)
NASDAQ:UTMD
Want to see UTMD full AI Analyst Report?
UTMD Stock Chart & Stats
$55.67
-$0.06(-0.11%)
At close: 4:00 PM EST
$55.67
-$0.06(-0.11%)
Day’s Range― - ―
52-Week Range$51.26 - $69.55
Previous CloseN/A
Volume4.21K
Average Volume (3M)15.88K
Market Cap
$219.13M
Enterprise Value$137.28M
Total Cash (Recent Filing)$85.76M
Total Debt (Recent Filing)$225.00K
Price to Earnings (P/E)16.4
Beta0.53
Next Earnings
Apr 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.15%
Share Statistics
EPS (TTM)0.80
Shares Outstanding3,185,025
10 Day Avg. Volume20,525
30 Day Avg. Volume15,884
Financial Highlights & Ratios
PEG Ratio-1.18
Price to Book (P/B)1.55
Price to Sales (P/S)4.81
P/FCF Ratio12.93
Enterprise Value/Market Cap0.63
Enterprise Value/Revenue3.56
Enterprise Value/Gross Profit6.73
Enterprise Value/Ebitda8.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage and substantial equity give the company durable financial flexibility. This conservatism supports stability through industry cycles, funds operational needs or opportunistic M&A without forcing external financing, and lowers default and refinancing risks over months.
Strong Profitability MarginsHigh gross and operating margins indicate structural pricing power or efficient manufacturing for its products. Sustained margin levels provide a cushion against cost pressures, enable reinvestment in R&D and commercial efforts, and support long-term free cash generation when volumes recover.
Recurring Consumable RevenueA product mix heavy in single‑use disposables tied to procedures creates predictable repeat purchases and customer stickiness. That structural revenue base tends to smooth sales volatility and supports long-term cash visibility from hospitals and providers.
Bears Say
Persistent Revenue DeclineMulti-year top-line contraction erodes scale and operating leverage, limiting the company’s ability to absorb fixed costs and invest in growth. If sustained, shrinking revenue undermines long-term earnings power, market presence, and R&D or commercial investment capacity.
Deteriorated Cash GenerationA sudden drop to zero operating cash flow and negative free cash flow marks a material weakening in cash conversion. Reduced internal cash limits capital allocation flexibility, strains the ability to sustain dividends or fund growth, and makes the firm more dependent on its balance sheet.
Margin Compression TrendDeclining gross and net margins suggest structural pressure from pricing, mix shifts, or rising costs. Continued compression will reduce the firm’s profitability buffer, lower returns on invested capital, and weaken long-term ability to fund strategic initiatives without sacrificing margins.
Utah Medical Products News
UTMD FAQ
What was Utah Medical Products’s price range in the past 12 months?
Utah Medical Products lowest stock price was $51.26 and its highest was $69.55 in the past 12 months.
What is Utah Medical Products’s market cap?
Utah Medical Products’s market cap is $219.13M.
When is Utah Medical Products’s upcoming earnings report date?
Utah Medical Products’s upcoming earnings report date is Apr 28, 2026 which is in 11 days.
How were Utah Medical Products’s earnings last quarter?
Utah Medical Products released its earnings results on Jan 29, 2026. The company reported $0.802 earnings per share for the quarter, beating the consensus estimate of N/A by $0.802.
Is Utah Medical Products overvalued?
According to Wall Street analysts Utah Medical Products’s price is currently Overvalued.
Does Utah Medical Products pay dividends?
Utah Medical Products pays a Quarterly dividend of $0.31 which represents an annual dividend yield of 2.15%. See more information on Utah Medical Products dividends here
What is Utah Medical Products’s EPS estimate?
Utah Medical Products’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Utah Medical Products have?
Utah Medical Products has 3,185,025 shares outstanding.
What happened to Utah Medical Products’s price movement after its last earnings report?
Utah Medical Products reported an EPS of $0.802 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.331%.
Which hedge fund is a major shareholder of Utah Medical Products?
Currently, no hedge funds are holding shares in UTMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Utah Medical Products Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
UTMD Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 13.4K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.23%
12-Months-Change
Fundamentals
Return on Equity
9.56%
Trailing 12-Months
Asset Growth
<0.01%
Trailing 12-Months
Company Description
Utah Medical Products
Utah Medical Products, Inc. (UTMD) is a leading medical device company focused on developing and manufacturing high-quality medical products primarily for the healthcare sector. Founded in 1978 and headquartered in Midvale, Utah, the company specializes in the design of innovative, proprietary products that cater to the needs of hospitals and healthcare professionals. UTMD's product lines include disposable devices used in critical areas such as neonatal care, urology, and surgical procedures, emphasizing safety and efficacy.
Technical Analysis
Ownership Overview
0.69% Insiders
17.72% Mutual Funds
0.83% Other Institutional Investors
69.49% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---